Close
CDMO Safety Testing 2026
Novotech

Press Releases

PerkinElmer Establishes New Direct Operations in Southern Africa to Expand Its Presence & Business in the Fast Developing Region

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it has opened direct operations in Midrand, South Africa. The new PerkinElmer Southern African headquarters...

Diffusion Pharmaceuticals Successfully Completes Phase I Brain Cancer Trial

Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain...

State of the Cure Report Finds Funding of Cure Research for Type 1 Diabetes Drops by Half

On November 19, 2012, the Juvenile Diabetes Cure Alliance announced the release of their annual research report, State of the Cure, which is the only analytical and comprehensive review of progress made toward a type 1 diabetes cure...

BioTime and BioTime Acquisition Corporation Announce Combined $10 Million Financing

BioTime, Inc. ย and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a non-binding letter of intent for a $10 million investment from a private investor to provide financing for the...

GE Healthcare scientist paired with Cardiff MP to share insights on cell therapy, science and policy-making

Dr. Michelle Janas from GE Healthcare Life Sciences recently swapped a lab coat for legislation, when she visited Jenny Willott MP at the House of Commons for a โ€œWeek in Westminsterโ€ as part of a unique โ€˜pairingโ€™ scheme...

Simcyp Signs Collaborative Research Agreement with US FDA to Extend Dog Simulator to Veterinary Medicines

Simcyp (now Certara) has entered into a Cooperative Research and Development Agreement (CRADA) with the US Food and Drug Administration (FDA) to further develop the Simcyp Dog model for the evaluation of drug products intended for use in...

Clovis Oncology Announces Negative Outcome of CO-101 in Pivotal LEAP Pancreatic Cancer Study

Clovis Oncology, Inc. ย today announced the results from its LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CO-101 versus gemcitabine in metastatic pancreatic cancer. There was no difference in overall survival between the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป